<?xml version="1.0" encoding="UTF-8"?>
<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <act name="section">
    <meta>
      <identification source="#ct-legislature">
        <FRBRWork>
          <FRBRthis value="/akn/us-ct/act/cgs/sec-17b-265e"/>
          <FRBRuri value="/akn/us-ct/act/cgs/sec-17b-265e"/>
          <FRBRdate date="2025-12-31" name="enacted"/>
          <FRBRauthor href="#ct-legislature"/>
          <FRBRcountry value="us-ct"/>
          <FRBRnumber value="17b-265e"/>
          <FRBRname value="CGS"/>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/akn/us-ct/act/cgs/sec-17b-265e/eng@2025-12-31"/>
          <FRBRuri value="/akn/us-ct/act/cgs/sec-17b-265e/eng@2025-12-31"/>
          <FRBRdate date="2025-12-31" name="publication"/>
          <FRBRauthor href="#arch"/>
          <FRBRlanguage language="eng"/>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/akn/us-ct/act/cgs/sec-17b-265e/eng@2025-12-31/main.xml"/>
          <FRBRuri value="/akn/us-ct/act/cgs/sec-17b-265e/eng@2025-12-31/main.xml"/>
          <FRBRdate date="2025-12-31" name="generation"/>
          <FRBRauthor href="#arch"/>
        </FRBRManifestation>
      </identification>
      <references source="#arch">
        <TLCOrganization eId="arch" href="https://cosilico.ai" showAs="Cosilico Arch"/>
        <TLCOrganization eId="ct-legislature" href="https://www.cga.ct.gov" showAs="Connecticut General Assembly"/>
      </references>
    </meta>
    <body>
      <chapter eId="chp_319v">
        <num>319v</num>
        <heading>Temporary Assistance for Needy Families</heading>
        <section eId="sec_17b_265e">
          <num>17b-265e</num>
          <heading>Medicare Part D Supplemental Needs Fund. Payment by department for nonformulary prescription drugs. Rebates required for pharmaceutical manufacturers. Contracts for supplemental rebates</heading>
          <content>
            <p>Sec. 17b-265e. Medicare Part D Supplemental Needs Fund. Payment by department for nonformulary prescription drugs. Rebates required for pharmaceutical manufacturers. Contracts for supplemental rebates.Section17b-265eis repealed, effective July 1, 2011.
(Return to ChapterTable of Contents)(Return toList of Chapters)(Return toList of Titles)</p>
          </content>
        </section>
      </chapter>
    </body>
  </act>
</akomaNtoso>